Privia Health Group, Inc. (PRVA) — Financial statements
Income statement, balance sheet, and cash flow for Privia Health Group, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 2,123↑22.3% | 1,736↑4.7% | 1,658↑22.2% | 1,357↑40.4% | 966 | |
| Cost of Revenue | 1,913↑22.7% | 1,560↑4.2% | 1,496↑22.5% | 1,222↑35.4% | 903 | |
| Gross Profit | 209↑18.4% | 177↑9.5% | 162↑19.8% | 135↑111.7% | 64 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 138↑9.5% | 126↑15.1% | 110↓15.4% | 130↓49.4% | 256 | |
| Selling & Marketing Expenses | 27↑2.6% | 26↑6.9% | 25↑25.3% | 20↓13.2% | 23 | |
| SG&A Expenses | 165↑8.3% | 153↑13.6% | 134↓10.1% | 149↓46.4% | 279 | |
| Other Expenses | 10↑36.3% | 7↑11.3% | 7↑42.9% | 5↑85.5% | 2 | |
| Operating Expenses | 175↑9.6% | 160↑13.5% | 141↓8.5% | 154↓45.2% | 281 | |
| Total Costs & Expenses | 2,089↑21.5% | 1,719↑5.0% | 1,637↑19.0% | 1,376↑16.2% | 1,184 | |
| Operating Results | ||||||
| Operating Income | 34↑101.6% | 17↓17.8% | 21↑208.0% | -19↑91.2% | -217 | |
| Depreciation & Amortization | 10↑36.3% | 7↑11.3% | 7↑42.9% | 5↑85.5% | 2 | |
| EBITDA | 44↑82.0% | 24↓10.8% | 27↑286.8% | -15↑93.2% | -215 | |
| EBIT | 34↑101.6% | 17↓17.8% | 21↑208.0% | -19↑91.2% | -217 | |
| Interest & Other Income | ||||||
| Net Interest Income | 10↓10.9% | 11↑30.1% | 8↑1444.6% | 0.54↑150.7% | -1 | |
| Interest Income | 10↓10.9% | 11↑30.1% | 8↑1444.6% | 0.54 | 0.00 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 1 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Income / Expenses | 10↓10.9% | 11↑30.1% | 8↑1444.6% | 0.54↑150.7% | -1 | |
| Income Before Tax | 44↑57.7% | 28↓4.0% | 29↑256.2% | -19↑91.5% | -219 | |
| Income Tax Expense | 14↑31.3% | 11↑35.4% | 8↑222.7% | -7↑76.6% | -28 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 30↑74.4% | 17↓18.9% | 21↑274.3% | -12↑93.7% | -191 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 23↑59.3% | 14↓37.7% | 23↑368.8% | -9↑95.4% | -188 | |
| Bottom-Line Net Income | 23↑59.3% | 14↓37.7% | 23↑368.8% | -9↑95.4% | -188 | |
| EPS (Basic) | 0.19↑58.3% | 0.12↓40.0% | 0.20↑357.7% | -0.08↑95.6% | -1.77 | |
| EPS (Diluted) | 0.18↑63.6% | 0.11↓42.1% | 0.19↑344.8% | -0.08↑95.6% | -1.77 | |
| Weighted Average Shares | 122↑2.3% | 119↑2.3% | 117↑5.5% | 111↑2.6% | 108 | |
| Weighted Average Diluted Shares | 129↑2.6% | 126↑0.7% | 125↑12.6% | 111↑2.6% | 108 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.